Patients with hidradenitis suppurativa experienced
In two of the largest Phase III trials conducted in hidradenitis suppurativa (HS), Cosentyx® (secukinumab) treatment
Globe Newswire4-02-2023, 06:41
Top 20 AI university graduates first Ph.D. cohort 7-06-2024, 16:48